液相色谱-串联质谱法同时检测血清胃泌素G34与G17的分析与临床性能
本研究建立液相色谱-串联质谱(LC-MS/MS)法同时定量血清胃泌素G17和G34,采用阴离子交换固相萃取制备样本,验证分析性能并与化学发光免疫分析(CLIA)和放射免疫分析(RIA)比较,分析了245份血清样本。该方法总运行时间6分钟,与CLIA和RIA相关性良好,G17+G34在87.5%胃泌素瘤患者中高于健康对照95百分位,G17对胃泌素瘤特异性最高。
要点
- LC-MS/MS可同时定量G17和G34,总运行时间6分钟,内标校正后无明显基质效应。
- G17+G34在87.5%胃泌素瘤患者中高于健康对照95百分位(18.1 pg/mL)。
- G17对胃泌素瘤最具特异性,临床特异性96.9%(切点209.8 pg/mL)。
核心结论
- LC-MS/MS法可同时定量血清G17和G34,有助于胃泌素浓度升高相关疾病的诊断。
研究设计与样本
- 方法学建立与验证研究,采用阴离子交换固相萃取制备血清样本,分析245份来自健康对照、胃泌素瘤患者和其他疾病患者的血清样本。
主要发现
- G17批内CV为4.0%-14.2%,总CV为5.2%-14.1%;G34批内CV为4.4%-10.4%,总CV为4.6%-12.4%。
- LC-MS/MS与CLIA的相关系数为0.87,与RIA的相关系数为0.84。
- 87.5%的胃泌素瘤患者G17+G34浓度高于健康对照95百分位(18.1 pg/mL),其他疾病患者与胃泌素瘤患者浓度有重叠。
- 基于Youden指数,G17是对胃泌素瘤最具特异性的生物标志物,临床特异性96.9%(切点209.8 pg/mL)。
临床怎么用
- 该方法可用于同时检测血清G17和G34,辅助胃泌素浓度升高相关疾病的诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two major forms of gastrin, gastrin-17 (G17) and gastrin-34 (G34), exist in blood. However, conventional immunoassay methods can only quantify total gastrin or G17 alone. Here, we aimed to establish a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to quantify G17 and G34 simultaneously. METHODS: Serum samples were prepared by anion-exchange solid-phase extraction. The analytical performance of the LC-MS/MS method was validated and the method was compared to chemiluminescence immunoassay (CLIA) and radioimmunoassay (RIA). The G17 and G34 concentrations in 245 serum samples from healthy controls, individuals with gastrinoma, and individuals with other diseases were analyzed. RESULTS: The total runtime of the LC-MS/MS method was 6 min. No substantial matrix effect was observed with internal standard correction. The intraassay coefficients of variation (CVs) for G17 and G34 were 4.0%-14.2% and 4.4%-10.4%, respectively, and total CVs were 5.2%-14.1% and 4.6%-12.4%, respectively. The correlation coefficient between LC-MS/MS and CLIA was 0.87, and between LC-MS/MS and RIA was 0.84. The G17+G34 concentrations for 87.5% of individuals with gastrinoma were higher than the 95th percentile of healthy controls (18.1 pg/mL), whereas the concentrations for individuals with other diseases and gastrinoma overlapped. Based on the Youden indices calculated for G17+G34, G34, and G17, the most specific biomarker was G17 (96.9% clinical specificity at 209.8 pg/mL) for gastrinoma. CONCLUSIONS: This method should aid in the diagnosis of diseases associated with increased gastrin concentrations.
引用
- Yu S, Wang D, Ma X, et al. Analytical and Clinical Performance of a Liquid Chromatography-Tandem Mass Spectrometry Method for Measuring Gastrin Subtypes G34 and G17 in Serum. Clin Chem. 2021. PMID: 34383899. doi:10.1093/clinchem/hvab097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。